An important contributor to world-wide knowledge in the field and a Canadian leader in the application of new treatment options.
Cardiac Surgery at the MUHC is one of the few programs in the world that offers complex medical and surgical cardiac care, seamlessly, from the newborn to the elderly patient. A recognized Canadian and international leader, the program has a long-standing tradition of innovation, including the use of stem cells for cardiac treatment.
The division steadily seeks improvement in clinical practice and research by means of routine analysis of results. This data is used in scientific collaboration with our partners in Intensive Care (ICU), Cardiology, Anesthesia, Geriatrics, Nephrology, Infectious Diseases and Gastro-enterology.
Our clinical efforts are directed towards complex care and involve novel techniques for:
- repairs of complex congenital cardiac anomalies,
- complex valvular and aortic reconstructions with the development of new valve repair techniques,
- assessment of the most recently introduced valve prostheses implanted either by open surgery or via minimally-invasive techniques,
- coordinated management of heart failure as part of a multispecialty team that provides optimal medical care, artificial heart technology, and heart transplantation.
With its evaluation of long-term outcomes of patients who are more than 60 years of age, cardiac surgery at the MUHC has made an important contribution to world-wide knowledge in the field. It has been a Canadian leader in the application of new treatment options for advanced heart failure patients.
The MUHC division of Cardiac Surgery is the sole provider of quaternary cardiac surgical care to the McGill integrated university health network in Quebec (RUIS).